Follow us on Facebook

One on One Support

Health Concerns
VA Issues  


Notice: Website under construction,

May 2014 VA Hep C Treatment Guidelines
UPDATE: Feb 26, 2016-
Funding and Prioritization Status Update

UPDATE: March 2016
VA Hep C Treatment Guidelines
VA to treat all vets in system

By Judith Graham
VA Extends New Hepatitis C Drugs to All Veterans in Its Health System

Orange Count Registry
Vietnam vets blame 'jet guns' for their hepatitis C
By Lily Leung Feb. 14, 2016 
CBS News Investigates
Congress outraged over hepatitis C treatment VA can't afford
Dr. Raymond Schinazi played a leading role developing a drug that cures hepatitis C while working seven-eighths of his time for the VA| By amynordrum

Hepatitis C drug costing VA, DoD millions
By Patricia Kime, Staff writer
We're looking at a company who is milking a cash cow for everything it's worth," Sanders said. 

VA to outsource care for 180,000 vets with hepatitis C
Dennis Wagner, The Arizona Republic 12:27 a.m. EDT June 21, 2015

VA to outsource care for 180,000 vets with hepatitis C
, The Republic | 11:51 a.m. MST June 19, 2015
Dr. David Ross, the VA's director public-health pathogens programs, resigned from the working group. "I cannot in good conscience continue to work on a plan for rationing care to veterans," he wrote.

VA Region Stops Referring Patients To Outside Hospitals Thanks To Budget Shortfall
Michael Volpe Contributor ...According to a memo — the entire region has been forced to stop all “non-VA care” referrals due to a budget shortfall.
Sen. Mark Kirk admitted the VA Choice Program is a failed joke in a letter to Secretary Bob McDonald despite attempts to fix it.

Denied Hep C VA dental care?
Please click here

Dried Hepatitis C Blood Exposure 11/23/2013 Weeks later inconspicuous blood transmits virus and more likely to cause accidental exposures to Hep C

Lack of Standards for
Mass Vaccinations
1970 Jetgun Nursing Instructions

2014 AASLD Study Hepatitis C not an STD

Test the Rest Campaign
Documentation & Surveillance Alerts
Military Hepatitis History  
Understanding The Liver 
VA Flow Sheet for Cirrhosis
VA Defines Risk Factors
Hep C & Pro-Prebiotic
Need to know-Grassroots Research
Blog Another12Weeks
One Vets' Journey Though Treatment

 Ask NOD
 What Would Veterans Do?
Blog for VA Claims

Help with VA Claims

Info: Plan Backfires-
VBA Fast Letter Boost Claims
Legal- Fed Regs state:
Judge decision may be relied upon
Cotant v. Principi, 17 Vet.App. 116, 134 (2003),
Service Connected Claims
# 1 Conclusion of Law 
# 2 Conclusion of Law 
More Claims
Jetgun Decisions
Hep C Decisions
Search Board of Appeals Website
BVA Jetgun Decisions
BVA Hepatitis C Decisions

Great Advice!  
After the jetgun win
What to do next


Contaminated Immunoglobulin Research

Atrah HI, Ala FA, Gough D. Blood exchanged in ritual ceremonies as a possible route for infection with hepatitis C virus. J Clin Pathol 1994 Jan;47(1):87.

Bjorkander J, Fasth A, Widell A. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience. Clin Ther 1996;18 Suppl B:73-82.

Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994 Dec 15;331(24):1607-11; N Engl J Med 1994 Dec 15;331(24):1649-50; N Engl J Med 1995 May 4;332(18):1235; discussion 1236-7; N Engl J Med 1995 May 4;332(18):1235-6.

Bresee JS, Mast EE, Coleman PJ, Baron MJ, Schonberger LB, Alter MJ, Jonas MM, Yu MY, Renzi PM, Schneider LC. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 1996 Nov 20;276(19):1563-7.

Couzigou P, Richard L, Dumas F, Schouler L, Fleury H. Detection of HCV-RNA in saliva of patients with chronic hepatitis C. Gut 1993;34(2 Suppl):S59-60.

Crowe J, Doyle C, Fielding JH, Holloway H, Keegan M, Kellcher D, Kelly P, Leader M, Little M, McDonald G, McCarthy CF, McWeeney J, O'Keane C, Rajan E/Walsh JK, Kenny Walsh L, Weir DG, Whelton M. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [abstract]. Gastroenterology 1995 Apr;108(4 Suppl):A1054.

Echevarria JM, Leon P, Domingo CJ, Lopez JA, Elola C, Madurga M, Salmeron F, Yap PL, Daub J, Simmonds P. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Transfusion 1996 Aug;36(8):725-30.

Feucht HH, Zollner B, Schroter M, Altrogge H, Laufs R. Tear fluid of hepatitis C virus carriers could be infectious. J Clin Microbiol 1995 Aug;33(8):2202-3.

Flora K, Schiele M, Benner K, Montanaro A, Johnston W, Whitham R, Press R. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin. Ann Allergy Asthma Immunol 1996 Feb;76(2):160-2.

From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994. JAMA 1994 Aug 10;272(6):424-5.

Gomperts ED. Gammagard and reported hepatitis C virus episodes. Clin Ther 1996;18 Suppl B:3-8.

Healey C, Chapel H. Intravenous immunoglobulin and hepatitis C virus: the British episode. Clin Ther 1996;18 Suppl B:93-5.

Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RW, Simmonds P, Chapel H. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology 1996 Apr;110(4):1120-6. Comment in: Gastroenterology 1996 Apr;110(4):1307-10.

Higashi H, Matsumata T, Hayashi J, Yanaga K, Shimada M, Shirabe K, Taketomi A, Kashiwagi S, Sugimachi K. Detection of hepatitis C virus RNA in the ultrasonic dissector irrigating solution used in liver surgery. Br J Surg 1994 Sep;81(9):1346-7.

Jonas MM, Baron MJ, Bresee JS, Schneider LC. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Pediatrics 1996 Aug;98(2 Pt 1):211-5.

Karna P, Murray DL, Valduss D, Mattarella N, Dyke JW, Maier GA. Passive transfer of hepatitis antibodies during intravenous administration of immune globulin. J Pediatr 1994 Sep;125(3):463-5. Comment in: J Pediatr 1995 Feb;126(2):321-2.

Lefrere JJ, Loiseau P, Martinot-Peignoux M, Mariotti M, Ravera N, Thauvin M, Marcellin P, Janot C. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France. Transfusion 1996 May;36(5):394-7.

McKee TA, Avery S, Majid A, Brinsden PR. Risks for transmission of hepatitis C virus during artificial insemination. Fertil Steril 1996 Jul;66(1):161-3.

Mele A, Corona R, Tosti ME, Palumbo F, Moiraghi A, Novaco F, Galanti C, Bernacchia R, Ferraro P. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis 1995;27(5):441-4.

Nelson SP, Jonas MM. Hepatitis C infection in children who received extracorporeal membrane oxygenation. J Pediatr Surg 1996 May;31(5):644-8.

Ollero M, Merino D, Pujol E, Marquez P, Gimeno A, Angulo C. Tattoos and hepatitis C virus infection [abstract]. Int Conf AIDS 1992 Jul 19-24;8(3):180 (abstract no. PuC 8163).

Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994. MMWR Morb Mortal Wkly Rep 1994 Jul 22;43(28):505-9.

Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995 May 13;345(8959):1211-3. Comment in: Lancet 1995 Aug 5;346(8971):372.

Power JP, Lawlor E, Davidson F, Yap PL, Kenny-Walsh E, Whelton MJ, Walsh TJ. Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin [letter]. Lancet 1994 Oct 22;344(8930):1166-7.

Purcell RH. Enterically transmitted non-A, non-B hepatitis. Prog Liver Dis 1990;9:497-504.

Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva [letter]. Scand J Infect Dis 1993;25(2):270-1.

Schneider LC, Jonas MM, Baron MJ, Mast EF, Alter MJ, Schonberger LB, Lambert S, Coleman P, Bresee JS. Intravenous immunoglobulin and hepatitis C virus: the Boston episode. Clin Ther 1996;18 Suppl B:108-9.

Slade HB. Human Immunoglobulins for intravenous use and hepatitis C viral transmission. Clin Diagn Lab Immunol 1994 Nov;1(6):613-9.

Webster AD, Brown D, Franz A, Dusheiko G. Prevalence of hepatitis C in patients with primary antibody deficiency. Clin Exp Immunol 1996 Jan;103(1):5-7.

Yap PL. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data. Clin Ther 1996;18 Suppl B:43-58.

Yap PL. The viral safety of intravenous immune globulin. Clin Exp Immunol 1996 May;104 Suppl 1:35-42.

Yap PL, McOmish F, Webster AD, Hammarstrom L, Smith CI, Bjorkander J, Ochs HD, Fischer SH, Quinti I, Simmonds P. Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol 1994 Sep;21(3):455-60.

Yu MW. Follow-up studies of hepatitis C association with an intravenous immunoglobulin. Dev Biol Stand 1996;88:215-6.

Yu MW, Mason BL, Guo ZP, Tankersley DL. Safety of intravenous immunoglobulin with regard to hepatitis C virus. Clin Ther 1996;18 Suppl B:71-2.